Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and rat CYP2A3

Nutrition and Cancer

Volumn 48, Issue 1, 2004, Pages 54-63

  Morris, Chantey R ^a   Chen, Sheng C ^a   Zhou, Lin ^a   Schopfer, Lawrence M ^a   Ding, Xinxin ^c   Mirvish, Sidney S ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPENE 1 THIOL; ALLYL SULFIDE; CYTOCHROME P450 2A; CYTOCHROME P450 2A3; CYTOCHROME P450 2E1; DIALLYL SULFONE; DIALLYL TRISULFIDE; METHYL N PENTYLNITROSAMINE; NITROSAMINE; PHENETHYL ISOTHIOCYANATE; SULFORAPHANE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CRUCIFERA; DEPENTYLATION; DIET; ENZYME ASSAY; ENZYME MECHANISM; ENZYME MODIFICATION; ESOPHAGUS CANCER; GARLIC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; MALE; MICROSOME; NONHUMAN; RAT;

ALLIUM SATIVUM; ANIMALIA; BRASSICACEAE;

EID: 3042692972     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4801_8     Document Type: Article

References (44)

1. Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93, 17-48, 1995 (erratum: 97, 201, 1995).
2. Huang Q, Lawson TA, Chung FL, and Mirvish SS: Inhibitory effect of phenylethyl and phenylhexyl isothiocyanate on metabolism of and DNA alkylation by N-nitrosomethylamylamine in the rat. Carcinogenesis 14, 749-754, 1993.
3. Chen SC, Zhou L, Ding X, and Mirvish SS: Depentylation of the rat esophageal carcinogen, methyl-n-pentylnitrosamine, by microsomes from various human and rat tissues and by cytochrome P450 2A3. Drug Metab Dispos 29, 1221-1228, 2001.
4. Gopalakrishnan R, Morse MA, Ju J, Weghorst CM, Sabourin CL, et al.: Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine. Carcinogenesis 20, 885-891, 1999.
5. Liu C, Zhuo XL, Gonzalez FJ, and Ding XX: Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2A6: role in metabolic activation of nasal toxicants. Mol Pharmacol 50, 781-788, 1996.
6. Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, et al.: Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone. Cancer Res 60, 5074-5079.
7. Brookman-Amissah N, Mackay AG, and Swann PF: Isolation and sequencing of the cDNA of a novel cytochrome P450 from rat oesophagus. Carcinogenesis 22, 155-160, 2001.
8. 3H-pentyl]-methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by human and rat cytochrome P450 isoforms. Cancer Res 59, 91-98, 1999.
9. Lawson LD, Wang ZYJ, and Hughes BG: Identification and HPLC quantitation of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Med 57, 363-370, 1991.
10. Egen-Schwind C, Eckard R, and Kemper FH: Metabolism of garlic constituents in the isolated perfused rat liver. Planta Med 58, 301-305, 1992.
11. Brady JF, Li D, Ishizaki H, and Yang CS: Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res 48, 5937-5940, 1988.
12. Jin L and Baillie TA: Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chem Res Toxicol 10, 318-327, 1997.
13. Yang CS, Chhabra SK, Hong JY, and Smith TJ: Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J Nutr 131, 1041S-1045S, 2001.
14. Brady JF, Ishizaki H, Fukuto JM, Lin MC, Fadel A, et al.: Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol 4, 642-647, 1991.
15. Bianchini F and Vainio H: Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect 109, 893-902, 2001.
16. Morris CR, Chen SC, Hinman C, and Mirvish SS: Inhibition of methyl-n-amylnitrosamine hydroxylation by diallyl sulfide and phenethyl isothiocyanate in the rat. Nutr Cancer 37, 81-88, 2000.
17. Verhoeven DTH, Goldbohm RA, Van Poppel G, Verhagen H, and Van Den Brandt PA: Epidemiological studies on Brassica vegetables and cancer risk. Cancer Epidem Biomark Prev 5, 733-748, 1996.
18. Hecht SS: Inhibition of carcinogenesis by isothiocyanates. Drug Metabolism Rev 32, 395-411, 2000.
19. Yang CS, Smith TJ, and Hong J-Y. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res 54(Suppl), 1982-1986, 1994.
20. Morris CR, Yao D, Chen SC, and Mirvish SS: Diallylsulfide inhibition of methyl-n-amylnitrosamine metabolism by P450s and fate of diallylsulfide and diallyldisulfide in rats. Proc Am Assoc Cancer Res 41, 661, 2000.
21. Zhou L, Morris CR, Chen SC, and Mirvish SS: Inhibition by garlic allylsulfides and phenethylisothiocyanate (PEITC) of methyl-n-pentylnitrosamine (MPN) depentylation by P450s/microsomes and of liver DNA alkylation by dimethylnitrosamine (DMN) in rats. J Nutr 132, 3551S, 2002.
22. Lunn G, Sansone EB, and Keefer LK: Safe disposal of carcinogenic nitrosamines. Carcinogenesis 4, 315-319, 1983.
23. Yang CS, Yoo J-SH, Ishizaki H, and Hong J: Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 22, 147-159, 1990.
24. Yoo JSH, Cheung RJ, Patten CJ, Wade D, and Yang CS: Nature of N-nitrosodimethylamine demethylase and its inhibitors. Cancer Res 47, 3378-3383, 1987.
25. Dixon M: The determination of enzyme inhibitor constants. Biochem J 55, 170-171, 1953.
26. Cornish-Bowden A: A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J 137, 143-144, 1974.
27. Hollenberg PF: Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab Rev 34, 17-35, 2002.
28. Mirvish SS, Huang Q, Ji C, Wang S, Park SS, et al.: Positional specificity for methyl-n-amylnitrosamine hydroxylation by cytochrome P-450 isozymes determined with monoclonal antibodies. Cancer Res 51, 1059-1064, 1991.
29. Yoo JSH, Ishizaki H, and Yang CS: Roles of cytochrome-P450IIE1 in the dealkylation and denitrosation of N-nitrosodimethylamine and N-nitrosodiethylamine in rat-liver microsomes. Carcinogenesis 11, 2239-2243, 1990.
30. Patten CJ, Ishizaki H, Aoyama T, Lee M, Ning SM, et al.: Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cells. Arch Biochem Biophys 299, 163-171, 1992.
31. Keefer LK and Fodor CH: Facile hydrogen isotope exchange as evidence for an a-nitrosamino carbanion. JAm Chem Soc 92, 5247-5248, 1970.
32. Botto F, Seree E, El Khyari S, De Sousa G, Massacrier A, et al.: Tissue-specific expression and methylation of the human CYP2E1 gene. Biochem Pharmacol 48, 1095-1103, 1994.
33. Lechevrel M, Casson AG, Wolf CR, Hardie LJ, Flinterman MB, et al.: Characterization of cytochrome P450 expression in human esophageal mucosa. Carcinogenesis 20, 243-248, 1999.
34. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, et al.: Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev 7, 1013-1018, 1998.
35. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, et al.: Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 6, 901-905, 1997.
36. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, et al.: CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. JNCI 89, 1207-1212, 1997.
37. Von Weymam LB and Murphy SE: Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3. Chem Res Toxicol 14, 1386-1392, 2001
38. Barcelo S, Gardiner JM, Gescher A, and Chipman JK: CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17, 277-282, 1996.
39. Smith EL, Hill RL, Lehman IR, Lefkowitz RJ, Handler P, and White A: Principles of Biochemistry, 7th ed. New York: McGraw Hill, 1983.
40. Fujita K and Kamataki T: Screening of organosulfur compounds as inhibitors of human CYP2A6. Drug Metab Dispos 29, 983-989, 2001.
41. Stoner GD, Morrissey DT, Heur Y-H, Daniel EM, Galati AJ, et al.: Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzyl-methylamine carcinogenesis in the rat esophagus. Cancer Res 51, 2063-2068, 1991.
42. Zhou L and Mirvish SS: Inhibition by garlic and its allyl sulfides of lung, kidney and liver DNA alkylation by dimethylnitrosamine in rats. Proc Am Assoc Cancer Res 44, 1098, 2003.
43. Dietz DD, Leininger JR, Rauckman EJ, Thompson MB, Chapin RE, et al.: Toxicity studies of acetone administered in the drinking water of rodents. Fund Appl Toxicol 17, 347-360, 1991.
44. Ogawa K, Hirose M, Sugiura S, Cui L, Imaida K, et al.: Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis. Nutr Cancer 40, 134-139, 2001.